219 related articles for article (PubMed ID: 26996301)
1. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.
Wang HH; Cui YL; Zaorsky NG; Lan J; Deng L; Zeng XL; Wu ZQ; Tao Z; Guo WH; Wang QX; Zhao LJ; Yuan ZY; Lu Y; Wang P; Meng MB
Cancer Lett; 2016 Jun; 375(2):349-359. PubMed ID: 26996301
[TBL] [Abstract][Full Text] [Related]
2. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
[TBL] [Abstract][Full Text] [Related]
3. Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.
Hamdan R; Zhou Z; Kleinerman ES
Mol Cancer Ther; 2014 Feb; 13(2):483-91. PubMed ID: 24282276
[TBL] [Abstract][Full Text] [Related]
4. Mechanical stretch upregulates SDF-1α in skin tissue and induces migration of circulating bone marrow-derived stem cells into the expanded skin.
Zhou SB; Wang J; Chiang CA; Sheng LL; Li QF
Stem Cells; 2013 Dec; 31(12):2703-13. PubMed ID: 23836581
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem and progenitor cell migration after hypofractionated radiation therapy in a murine model.
Kane J; Krueger SA; Dilworth JT; Torma JT; Wilson GD; Marples B; Madlambayan GJ
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1162-70. PubMed ID: 24113056
[TBL] [Abstract][Full Text] [Related]
7. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.
Chen W; Li M; Cheng H; Yan Z; Cao J; Pan B; Sang W; Wu Q; Zeng L; Li Z; Xu K
Cell Biochem Biophys; 2013; 67(3):1181-91. PubMed ID: 23712865
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells.
Windmolders S; De Boeck A; Koninckx R; Daniëls A; De Wever O; Bracke M; Hendrikx M; Hensen K; Rummens JL
J Mol Cell Cardiol; 2014 Jan; 66():177-88. PubMed ID: 24326234
[TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery.
Filomeno PA; Kim KP; Yoon N; Rashedi I; Dayan V; Kandel RA; Wang XH; Felizardo TC; Berinstein E; Jelveh S; Filomeno A; Medin JA; Ferguson PC; Keating A
Cytotherapy; 2018 Aug; 20(8):1001-1012. PubMed ID: 30076069
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor receptor beta identifies mesenchymal stem cells with enhanced engraftment to tissue injury and pro-angiogenic property.
Wang S; Mo M; Wang J; Sadia S; Shi B; Fu X; Yu L; Tredget EE; Wu Y
Cell Mol Life Sci; 2018 Feb; 75(3):547-561. PubMed ID: 28929173
[TBL] [Abstract][Full Text] [Related]
14. Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway.
Chen FH; Fu SY; Yang YC; Wang CC; Chiang CS; Hong JH
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):777-84. PubMed ID: 23601898
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.
Suzuki K; Sun R; Origuchi M; Kanehira M; Takahata T; Itoh J; Umezawa A; Kijima H; Fukuda S; Saijo Y
Mol Med; 2011; 17(7-8):579-87. PubMed ID: 21424106
[TBL] [Abstract][Full Text] [Related]
17. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
[TBL] [Abstract][Full Text] [Related]
18. Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1alpha.
Li N; Lu X; Zhao X; Xiang FL; Xenocostas A; Karmazyn M; Feng Q
Stem Cells; 2009 Apr; 27(4):961-70. PubMed ID: 19353524
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
20. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
